Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Itraconazole

Treatment failure

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kim JH, et al. Therapeutic Use of Posaconazole for Cutaneous Purpureocillium lilacinum Infection Refractory to Itraconazole. Korean Journal of Medical Mycology 28 : 79-83, No. 3, Sep 2023. Available from: URL: https://dx.doi.org/10.17966/JMI.2023.28.3.79 Kim JH, et al. Therapeutic Use of Posaconazole for Cutaneous Purpureocillium lilacinum Infection Refractory to Itraconazole. Korean Journal of Medical Mycology 28 : 79-83, No. 3, Sep 2023. Available from: URL: https://​dx.​doi.​org/​10.​17966/​JMI.​2023.​28.​3.​79
Metadaten
Titel
Itraconazole
Treatment failure
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-49600-9

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics

Case report

Pembrolizumab

Case report

Multiple drugs

Case report

Hydroxycarbamide